Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis
Information source: Hospital Israelita Albert Einstein
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Hyperhidrosis
Intervention: Oxybutynin (Drug)
Phase: N/A
Status: Completed
Sponsored by: Hospital Israelita Albert Einstein Official(s) and/or principal investigator(s): Nelson Wolosker, PhD, MD, Principal Investigator, Affiliation: Hospital Israelita Albert Einstein
Summary
Evaluate the long term efficacy and side effects of oxybutynin in the treatment of
hyperhidrosis.
Clinical Details
Official title: Retrospective Evaluation of Long Term Use of Oxybutynin in the Pharmacological Treatment of Primary Hyperhidrosis
Study design: Observational Model: Cohort, Time Perspective: Retrospective
Primary outcome: Quality of lifeQuality of life
Secondary outcome: Perception of improvement in excessive sweatingPerception of improvement in excessive sweating
Detailed description:
This retrospective study aims to evaluate the medical charts of patients who were treated
with oxybutynin for at least six months for primary hyperhidrosis. The investigators
variables of interest are: (1) quality of life before pharmacological therapy and after six
weeks, (2)self-perception of improvement in hyperhidrosis after six weeks of treatment and
on last visit (whenever this occur, as long as this happens after six months), (3) side
effects related to drug use.
Eligibility
Minimum age: 5 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Primary hyperhidrosis
- At least 180 days of treatment with oxybutynin
Exclusion Criteria:
- Incomplete medical chart
- Patients with glaucoma
Locations and Contacts
Hospital Israelita Albert Einstein, São Paulo 05652000, Brazil
Additional Information
Related publications: Wolosker N, Schvartsman C, Krutman M, Campbell TP, Kauffman P, de Campos JR, Puech-Leão P. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old. Pediatr Dermatol. 2014 Jan-Feb;31(1):48-53. doi: 10.1111/pde.12142. Epub 2013 Apr 29. Wolosker N, de Campos JR, Kauffman P, Yazbek G, Neves S, Puech-Leao P. Use of oxybutynin for treating plantar hyperhidrosis. Int J Dermatol. 2013 May;52(5):620-3. doi: 10.1111/j.1365-4632.2012.05746.x. Wolosker N, Krutman M, Campdell TP, Kauffman P, Campos JR, Puech-Leão P. Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders. Einstein (Sao Paulo). 2012 Oct-Dec;10(4):405-8. English, Portuguese. Wolosker N, de Campos JR, Kauffman P, Puech-Leão P. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg. 2012 Jun;55(6):1696-700. doi: 10.1016/j.jvs.2011.12.039. Epub 2012 Feb 16. Wolosker N, de Campos JR, Kauffman P, Neves S, Munia MA, BiscegliJatene F, Puech-Leão P. The use of oxybutynin for treating axillary hyperhidrosis. Ann Vasc Surg. 2011 Nov;25(8):1057-62. doi: 10.1016/j.avsg.2011.06.007. Wolosker N, Campos JR, Kauffman P, Munia MA, Neves S, Jatene FB, Puech-Leão P. The use of oxybutynin for treating facial hyperhidrosis. An Bras Dermatol. 2011 May-Jun;86(3):451-6. Wolosker N, de Campos JR, Kauffman P, Neves S, Yazbek G, Jatene FB, Puech-Leão P. An alternative to treat palmar hyperhidrosis: use of oxybutynin. Clin Auton Res. 2011 Dec;21(6):389-93. doi: 10.1007/s10286-011-0128-4. Epub 2011 Jun 19. Try C, Messikh R, Elkhyat A, Aubin F, Humbert RP. [Use of oral oxybutynin at 7.5 mg per day in primary hyperhidrosis]. Rev Med Liege. 2012 Oct;67(10):520-6. French. Maillard H, Fenot M, Bara C, Célérier P. [Therapeutic value of moderate-dose oxybutynin in extensive hyperhidrosis]. Ann Dermatol Venereol. 2011 Oct;138(10):652-6. doi: 10.1016/j.annder.2011.07.002. Epub 2011 Aug 17. French. Lefrandt JD, Maurer JM. Oxybutynin for hyperhidrosis. Neth J Med. 2007 Oct;65(9):356. Schollhammer M, Misery L. Treatment of hyperhidrosis with oxybutynin. Arch Dermatol. 2007 Apr;143(4):544-5. Mijnhout GS, Kloosterman H, Simsek S, Strack van Schijndel RJ, Netelenbos JC. Oxybutynin: dry days for patients with hyperhidrosis. Neth J Med. 2006 Oct;64(9):326-8. Review. Tupker RA, Harmsze AM, Deneer VH. Oxybutynin therapy for generalized hyperhidrosis. Arch Dermatol. 2006 Aug;142(8):1065-6.
Starting date: September 2007
Last updated: October 7, 2013
|